We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Siemens Celebrates Success of Urine Chemistry Analyzer

By Labmedica staff writers
Posted on 16 Jul 2008
Placement of the 50,000th Clinitek Status urine chemistry analyzer, manufactured by Siemens (Sudbury, UK), was specially marked with a commemorative plaque handed over by Donal Quinn, CEO of Siemens Healthcare Diagnostics, to Lynda Petley, point-of-care manager, Partnership Pathology Services (Frimley, UK) at a ceremony held to mark the occasion.

"This 50,000th placement marks a milestone for Siemens. More...
The Clinitek Status analyzer has been popular amongst customers since launched in November 2003, and continues to be adopted because it fulfils customers' needs for automated, accurate urinalysis readings.” commented Mr. Quinn.

To mark the occasion, a commemorative gold medal was presented to the production site and employees were each given a gold medal. Celebratory events will also take place at the Siemens R&D sites in Elkhart, IN, and Edgewater, MA (USA).

Clinik Status urine analyzers provide important markers to detect early stages of many disease states, such as diabetes, kidney disease, and urinary tract infections. They are used in both secondary and primary care settings. They are robust, simple to use, cost-effective, and provide accurate results transferred in printouts to lab personnel.


Related Links:
Siemens Healthcare Diagnostics
Partnership Pathology Services

New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Total Laboratory Automation Solution
SATLARS Mini T8
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.